Sowell Financial Services LLC Insmed Inc Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$24.17 - $36.01 $1,691 - $2,520	-70 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$32.28 - $44.3 $7,747 - $10,632	-240 Reduced 77.42%	70 $2,000
Q4 2020 Jan 13, 2021	BUY	$31.45 - $40.54 $5,094 - $6,567	162 Added 109.46%	310 $10,000
Q3 2020 Nov 12, 2020	SELL	$26.0 - $34.5 $4,004 - $5,313	-154 Reduced 50.99%	148 $5,000
Q2 2020 Aug 13, 2020	SELL	$14.11 - $29.42 $18,117 - $37,775	-1,284 Reduced 80.96%	302 $8,000
Q1 2020 May 12, 2020	SELL	$13.63 - $33.98 $14,993 - $37,378	-1,100 Reduced 40.95%	1,586 $25,000
Q4 2019 Feb 07, 2020	BUY	$16.12 - $24.98 $43,298 - $67,096	2,686 New	2,686 $64,000

484

187M

2.15M

3.22M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.